A new test for cervical cancer was found to detect all of the cancers in a randomised clinical screening trial of 15,744 women, outperforming both the current Pap smear and human papillomavirus (HPV) test at a reduced cost, according to a study led by Queen Mary University of London.
The study, published in the International Journal of Cancer, compared a new ‘epigenetics-based’ cervical cancer test with Pap smear and HPV tests, and investigated how well it predicted the development of cervical cancer up to five years in advance in a large study of women aged 25-65 in Canada.
As opposed to checking for patterns in the DNA genetic code itself that are indicative of the HPV virus, the new test looks at the naturally-occurring chemical markers that appear on top of the DNA, making up its ‘epigenetic profile’.
‘An enormous development’
Lead researcher Professor Attila Lorincz from Queen Mary’s Wolfson Institute of Preventive Medicine who also helped develop the world’s first test for HPV in 1988, said: “This is an enormous development. We’re not only astounded by how well this test detects cervical cancer, but it is the first time that anyone has proven the key role of epigenetics in the development of a major solid cancer using data from patients in the clinic. Epigenetic changes are what this cervical cancer test picks up and is exactly why it works so well.
“In contrast to what most researchers and clinicians are saying, we are seeing more and more evidence that it is in fact epigenetics, and not DNA mutations, that drives a whole range of early cancers, including cervical, anal, oropharyngeal, colon, and prostate.”
Screening to prevent cervical cancer is typically done through the Pap smear, which involves the collection, staining and microscopic examination of cells from the cervix. Unfortunately, the Pap smear can detect only around 50 per cent of cervical pre-cancers.
A much more accurate cervical screening method involves testing for the presence of DNA from the human papillomavirus (HPV) – the primary but indirect cause of cervical cancer. There are estimated to be around 10 million women in the UK who are infected by HPV.
However, the HPV test only identifies whether or not women are infected with a cancer-causing HPV, but not their actual risks of cancer, which remain quite low. This causes unnecessary worry for the majority of HPV-infected women who receive a positive result but will eventually clear the virus and not develop the disease.
Predicting a person’s risk of cervical cancer
The new test was significantly better than either the Pap smear or HPV test. It detected 100 per cent of the eight invasive cervical cancers that developed in the 15,744 women during the trial. In comparison, the Pap smear only detected 25 per cent of the cancers, and the HPV test detected 50 per cent.
The study also looked more closely at a subset of 257 HPV-positive women which were representatively selected from the large study. The new test detected 93 per cent of pre-cancerous lesions in those women, compared to 86 per cent detected using a combination of the Pap smear and HPV test, and 61 per cent detected using the Pap smear on its own.
Reducing the number of screening appointments needed
Professor Lorincz added: “This really is a huge advance in how to deal with HPV-infected women and men, numbering in the billions worldwide, and it is going to revolutionise screening.
“We were surprised by how well this new test can detect and predict early cervical cancers years in advance, with 100 per cent of cancers detected, including adenocarcinomas, which is a type of cervical cancer that is very difficult to detect. The new test is much better than anything offered in the UK at present but could take at least five years to be established.”
The authors say that using this test in the clinic would reduce the number of visits to the doctor and screening appointments, as high-grade disease would be detected from the start. They also say that if it was fully implemented, it would be cheaper than the Pap smear.
The Latest on: Cervical cancer
via Google News
The Latest on: Cervical cancer
- A weak immune system may be reason for cervical canceron January 12, 2021 at 6:36 pm
Experts estimate that approximately 1 in 53 Indian women will get cervical cancer during their lifetime and currently, India accounts for nearly one-third of the global cervical cancer deaths.
- Record drop in cancer mortality for second straight year due to improved lung cancer treatmenton January 12, 2021 at 10:24 am
Overall cancer death rates in the United States dropped continuously from 1991 through 2018 for a total decrease of 31%, including a 2.4% decline from 2017 to 2018. The news comes from the American ...
- Discover Cervical Cancer Drugs Market to grow at a much faster rate beyond 2020| Financial Analysis and Forecaston January 12, 2021 at 6:11 am
A recent market report printed on the Cervical Cancer Drugs Market presents an associate in-depth summary of the Cervical Cancer Drugs market. World Cervical Cancer Drugs research report covers the ...
- More than $180K raised for 'selfless' Regina social worker after unexpected cancer diagnosison January 11, 2021 at 2:52 pm
More than $180,000 was raised in five days to help treat a Regina social worker's cancer. Katie Daschuk was diagnosed with cervical cancer in July last year. "She had normal pap smears in the past. So ...
- January Is Cervical Cancer Awareness Month With Emphasis On Prevention, Vaccineon January 11, 2021 at 11:43 am
According to the CDC, in the past 40 years, the number of cases of cervical cancer and the number of deaths have dropped dramatically.
- West: What you need to know about HPV and cervical canceron January 10, 2021 at 3:27 am
Nearly 13,000 women in the United States are diagnosed with cervical cancer each year. This month, I invited Dr. Amy Vance, board certified gynecologist, to address a few questions. The focus is on ...
- What we as women need to know: Cervical Cancer Awareness Monthon January 8, 2021 at 4:00 pm
Each and every woman is at risk of cervical cancer, and awareness is the first step towards prevention. Cervical cancer is a preventable disease.
- Babies Get Cervical Cancer From Mom During Birth: Two Cases Reportedon January 6, 2021 at 3:16 pm
Vaginal transmission of cervical cancer -- a phenomenon that has not been previously reported -- was detected in two pediatric patients, researchers in Japan reported. Two children whose mothers had ...
- Genmab (GMAB) Begins Phase III Study on Cervical Cancer Drugon January 5, 2021 at 10:36 am
Denmark-based biotech Genmab A/S GMAB announced that it has initiated a phase III study evaluating the investigational antibody-drug conjugate tisotumab vedotin as compared to chemotherapy for ...
- Longmont woman shares cervical cancer survival story to continue advocacyon January 2, 2021 at 8:53 pm
A Longmont woman who inspired a city-wide proclamation to dedicate January as cervical cancer awareness month is continuing her advocacy of the disease as a survivor.
via Bing News